Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Iatrogenic mediastinitis in bronchiolitis: Importance of avoiding pharyngeal aspiration.

Le Roch M, Thebault E, Beaudoin S, Rubinsztajn R, Chevallier B, Tavière V, Benoist G.

Arch Pediatr. 2019 Jul 2. pii: S0929-693X(19)30097-1. doi: 10.1016/j.arcped.2019.05.009. [Epub ahead of print]

PMID:
31278025
2.

Impact of a Single Session of Inhalation Technique Training on Inhalation Skills and the Course of Asthma and COPD.

Dabrowska M, Luczak-Wozniak K, Miszczuk M, Domagala I, Lubanski W, Leszczynski A, Maskey-Warzechowska M, Rubinsztajn R, Hermanowicz-Salamon J, Krenke R.

Respir Care. 2019 Jun 18. pii: respcare.06740. doi: 10.4187/respcare.06740. [Epub ahead of print]

PMID:
31213572
3.

Comorbidities in chronic obstructive pulmonary disease: Results of a national multicenter research project.

Rubinsztajn R, Przybyłowski T, Grabicki M, Karwat K, Maskey-Warzęchowska M, Batura-Gabryel H, Chazan R.

Adv Clin Exp Med. 2019 Mar;28(3):319-324. doi: 10.17219/acem/78024.

4.

Serum testosterone depression as a factor influencing the general condition in chronic obstructive pulmonary disease patients.

Rubinsztajn R, Przybyłowski T, Maskey-Warzęchowska M, Karwat K, Chazan R.

Adv Clin Exp Med. 2019 Jun;28(6):783-788. doi: 10.17219/acem/94153.

5.

Serum Vitamin D Concentration and Markers of Bone Metabolism in Perimenopausal and Postmenopausal Women with Asthma and COPD.

Białek-Gosk K, Rubinsztajn R, Białek S, Paplińska-Goryca M, Krenke R, Chazan R.

Adv Exp Med Biol. 2018;1070:27-36. doi: 10.1007/5584_2018_157.

PMID:
29564774
6.

COPD Course and Comorbidities: Are There Gender Differences?

Grabicki M, Kuźnar-Kamińska B, Rubinsztajn R, Brajer-Luftmann B, Kosacka M, Nowicka A, Piorunek T, Kostrzewska M, Chazan R, Batura-Gabryel H.

Adv Exp Med Biol. 2019;1113:43-51. doi: 10.1007/5584_2018_160.

PMID:
29488205
7.

The association between serological features of chronic Chlamydia pneumoniae infection and markers of systemic inflammation and nutrition in COPD patients.

Paplińska-Goryca M, Rubinsztajn R, Nejman-Gryz P, Przybyłowski T, Krenke R, Chazan R.

Scand J Clin Lab Invest. 2017 Dec;77(8):644-650. doi: 10.1080/00365513.2017.1393694. Epub 2017 Oct 25.

PMID:
29069917
8.

Metastasising leiomyoma of the uterus with pulmonary involvement - case report.

Maskey-Warzęchowska M, Chojnowska M, Ptaszyński K, Rubinsztajn R, Padzik-Moczydłowska M, Krenke R.

Adv Respir Med. 2017;85(4):211-215. doi: 10.5603/ARM.2017.0035.

PMID:
28871589
9.

Metabolic Syndrome as a Factor Affecting Systemic Inflammation in Patients with Chronic Obstructive Pulmonary Disease.

Rubinsztajn R, Przybyłowski T, Maskey-Warzęchowska M, Paplińska-Goryca M, Nejman-Gryz P, Karwat K, Chazan R.

Adv Exp Med Biol. 2017;1021:55-62. doi: 10.1007/5584_2017_28.

PMID:
28382609
10.

[Body composition analysis performed by bioimpedance in patients with chronic obstructive pulmonary disease].

Rubinsztajn R, Przybyłowski T, Maskey-Warzęchowska M, Karwat K, Chazan R.

Pol Merkur Lekarski. 2016 Oct 19;41(244):180-183. Polish.

PMID:
27760091
11.

Monoclonal Antibodies for the Management of Severe Asthma.

Rubinsztajn R, Chazan R.

Adv Exp Med Biol. 2016;935:35-42. doi: 10.1007/5584_2016_29. Review.

PMID:
27334730
12.

Impact of I/D polymorphism of ACE gene on risk of development and course of chronic obstructive pulmonary disease.

Mlak R, Homa-Mlak I, Powrózek T, Mackiewicz B, Michnar M, Krawczyk P, Dziedzic M, Rubinsztajn R, Chazan R, Milanowski J, Małecka-Massalska T.

Arch Med Sci. 2016 Apr 1;12(2):279-87. doi: 10.5114/aoms.2015.50757. Epub 2016 Apr 12.

14.

Serum levels of apoptosis-related markers (sFasL, TNF-a, p53 and bcl-2) in COPD patients.

Kosacka M, Porębska I, Korzeniewska A, Rubinsztajn R, Grabicki M, Jankowska R, Batura-Gabryel H, Chazan R.

Pneumonol Alergol Pol. 2016;84(1):11-5. doi: 10.5603/PiAP.a2015.0080. Epub 2015 Dec 21.

15.

Exacerbations of Chronic Obstructive Pulmonary Disease and Quality of Life of Patients.

Rubinsztajn R, Przybyłowski T, Maskey-Warzechowska M, Karwat K, Chazan R.

Adv Exp Med Biol. 2016;884:69-74.

PMID:
26542597
16.

The Prevalence of Oral Inflammation Among Denture Wearing Patients with Chronic Obstructive Pulmonary Disease.

Przybyłowska D, Rubinsztajn R, Chazan R, Swoboda-Kopeć E, Kostrzewa-Janicka J, Mierzwińska-Nastalska E.

Adv Exp Med Biol. 2015;858:87-91. doi: 10.1007/5584_2015_128.

PMID:
25820669
17.

Correlation between hyperinflation defined as an elevated RV/TLC ratio and body composition and cytokine profile in patients with chronic obstructive pulmonary disease.

Rubinsztajn R, Przybyłowski T, Maskey-Warzęchowska M, Paplińska-Goryca M, Karwat K, Nejman-Gryz P, Chazan R.

Pneumonol Alergol Pol. 2015;83(2):120-5. doi: 10.5603/PiAP.2015.0019.

18.

Potential respiratory pathogens colonisation of the denture plaque of patients with chronic obstructive pulmonary disease.

Przybyłowska D, Mierzwińska-Nastalska E, Swoboda-Kopeć E, Rubinsztajn R, Chazan R.

Gerodontology. 2016 Sep;33(3):322-7. doi: 10.1111/ger.12156. Epub 2014 Nov 12.

PMID:
25393518
19.

Influence of denture plaque biofilm on oral mucosal membrane in patients with chronic obstructive pulmonary disease.

Przybyłowska D, Mierzwińska-Nastalska E, Rubinsztajn R, Chazan R, Rolski D, Swoboda-Kopeć E.

Adv Exp Med Biol. 2015;839:25-30. doi: 10.1007/5584_2014_42.

PMID:
25252900
20.

Effect of exacerbation frequency on body composition and serum ghrelin and adiponectin concentrations in patients with chronic obstructive pulmonary disease.

Rubinsztajn R, Przybyłowski T, Maskey-Warzęchowska M, Karwat K, Paplińska-Goryca M, Nejman-Gryz P, Chazan R.

Pol Arch Med Wewn. 2014;124(7-8):403-9. Epub 2014 May 30.

21.

[Estimation of volume of pleural fluid and its impact on spirometrical parameters].

Karwat K, Przybyłowski T, Bielicki P, Hildebrand K, Nowacka-Mazurek M, Nasiłowski J, Rubinsztajn R, Chazan R.

Pol Merkur Lekarski. 2014 Mar;36(213):186-90. Polish.

PMID:
24779217
22.

[GOLD 2011 - COPD from a new perspective].

Rubinsztajn R, Przybyłowski T, Maskey-Warzechowska M, Karwat K, Chazan R.

Pol Merkur Lekarski. 2013 Apr;34(202):192-5. Polish.

PMID:
23745323
23.

[Usefulness of NT-proBNP serum level in the diagnosis of dyspnea in COPD patients].

Rubinsztajn R, Nasiłowski J, Przybyłowski T, Karwat K, Chazan R.

Pneumonol Alergol Pol. 2013;81(1):24-9. Polish.

24.

Expression of eotaxins in the material from nasal brushing in asthma, allergic rhinitis and COPD patients.

Paplińska M, Hermanowicz-Salamon J, Nejman-Gryz P, Białek-Gosk K, Rubinsztajn R, Arcimowicz M, Placha G, Góra J, Chazan R, Grubek-Jaworska H.

Cytokine. 2012 Nov;60(2):393-9. doi: 10.1016/j.cyto.2012.07.001. Epub 2012 Jul 28.

PMID:
22846146
25.

[Mortality and comorbidity in hospitalized chronic obstructive pulmonary disease patients].

Rubinsztajn R, Chazan R.

Pneumonol Alergol Pol. 2011;79(5):343-6. Polish.

26.
27.

[Enzyme replacement therapy of lysosomal storage diseases].

Germain DP, Boucly C, Carlier RY, Caudron E, Charlier P, Colas F, Jabbour F, Martinez V, Mokhtari S, Orlikowski D, Pellegrini N, Perronne C, Prigent H, Rubinsztajn R, Benistan K.

Rev Med Interne. 2010 Dec;31 Suppl 2:S279-91. doi: 10.1016/S0248-8663(10)70028-X. French.

PMID:
21211680
28.

[A neonatal case of immunoallergic acute interstitial nephritis].

Essid A, Allani-Essid N, Rubinsztajn R, Estournet B, Bataille J.

Arch Pediatr. 2010 Nov;17(11):1559-61. doi: 10.1016/j.arcped.2010.08.014. Epub 2010 Sep 28. French.

PMID:
20880680
29.

Novel FOXG1 mutations associated with the congenital variant of Rett syndrome.

Mencarelli MA, Spanhol-Rosseto A, Artuso R, Rondinella D, De Filippis R, Bahi-Buisson N, Nectoux J, Rubinsztajn R, Bienvenu T, Moncla A, Chabrol B, Villard L, Krumina Z, Armstrong J, Roche A, Pineda M, Gak E, Mari F, Ariani F, Renieri A.

J Med Genet. 2010 Jan;47(1):49-53. doi: 10.1136/jmg.2009.067884. Epub 2009 Jul 2.

PMID:
19578037
30.

[Serum concentration of homocysteine and the risk of atherosclerosis in patients with obstructive sleep apnea syndrome].

Kumor M, Rubinsztajn R, Byśkiniewicz K, Bielicki P, Chazan R.

Pneumonol Alergol Pol. 2006;74(1):117-21. Polish.

PMID:
17175990
31.

[The interpretation of carbon monoxide diffusing capacity test depending of hemoglobin concentration].

Rubinsztajn R, Wrotek K, Krenke R, Przybyłowski T, Chazan R.

Pneumonol Alergol Pol. 2006;74(1):113-6. Polish.

PMID:
17175989
32.
33.

[Serum leptin concentration and sympathetic activation estimated on the adrenaline and noradrenaline serum concentration in patients with obstructive sleep apnea].

Rubinsztajn R, Kumor M, Byśkiniewicz K, Bielicki P, Chazan R.

Pol Arch Med Wewn. 2005 Jun;113(6):544-51. Polish.

PMID:
16454443
34.

[A case report of severe hypophosphatemia in the course of refeeding syndrome].

Słodkowski M, Rubinsztajn R, Cebulski W, Krasnodebski IW.

Pol Merkur Lekarski. 2004 Dec;17(102):638-9. Polish.

PMID:
15771140
35.

[Angiotensin-converting enzyme gene polymorphism in patients with obstructive sleep apnea].

Rubinsztajn R, Kumor M, Byśkiniewicz K, Chazan R.

Pol Arch Med Wewn. 2004 Jul;112(1):817-22. Polish.

PMID:
15526842
36.
37.

[Asthma-induced myocardial infarction in a 39-year-old woman].

Rubinsztajn R, Nasiłowski J, Chazan R.

Pol Merkur Lekarski. 2003 Sep;15(87):253-5. Polish.

PMID:
14679851
38.

[Lung cancer in COPD--a clinical analysis].

Maskey-Warzechowska M, Domagała-Kulawik J, Rubinsztajn R, Chazan R.

Pol Arch Med Wewn. 2002 Aug;108(2):769-75. Polish.

PMID:
12476897
39.

Prognostic value of evoked potentials and sleep recordings in the prolonged comatose state of children. Preliminary data.

Chéliout-Heraut F, Rubinsztajn R, Ioos C, Estournet B.

Neurophysiol Clin. 2001 Oct;31(5):283-92.

PMID:
11817270
40.
41.

[Current opinions about the role of peptide C in the human organism].

Zdrojewicz Z, Krzyzanowska P, Januszewski A, Rubinsztajn R.

Postepy Hig Med Dosw. 1998;52(3):269-81. Review. Polish.

PMID:
9789436

Supplemental Content

Loading ...
Support Center